These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2135009)

  • 81. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Continuous epidural narcotic analgesia for intractable pain due to malignancy.
    Yablonski-Peretz T; Klin B; Beilin Y; Warner E; Baron S; Olshwang D; Catane R
    J Surg Oncol; 1985 May; 29(1):8-10. PubMed ID: 3838779
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain.
    Andersen G; Sjøgren P; Hansen SH; Jensen NH; Christrup L
    Eur J Pain; 2004 Jun; 8(3):263-71. PubMed ID: 15109977
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Perioperative dilemma: challenges of the management of a patient on mega doses of morphine and methadone.
    Kaye AD; Alian AA; Vadivelu N; Chung KS
    J Opioid Manag; 2014; 10(1):69-72. PubMed ID: 24604572
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Management of refractory pain in hospitalized adolescents with sickle cell disease: changing from intravenous opioids to continuous infusion epidural analgesia.
    New T; Venable C; Fraser L; Rosenberg E; Schmidt J; James-Herry A; Osunkwo I; Dampier C
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e398-402. PubMed ID: 24136017
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life].
    Yamazaki M; Aoki T; Tachibana M; Akashi T
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):217-21. PubMed ID: 16484859
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Continuous intravenous analgesia with fentanyl or morphine after gynecological surgery: a cohort study.
    Russo A; Grieco DL; Bevilacqua F; Anzellotti GM; Scarano A; Scambia G; Costantini B; Marana E
    J Anesth; 2017 Feb; 31(1):51-57. PubMed ID: 27743121
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery.
    Stoker DG; Reber KR; Waltzman LS; Ernst C; Hamilton D; Gawarecki D; Mermelstein F; McNicol E; Wright C; Carr DB
    Pain Med; 2008; 9(1):3-12. PubMed ID: 18254761
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
    Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
    Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine.
    Sjøgren P; Jonsson T; Jensen NH; Drenck NE; Jensen TS
    Pain; 1993 Oct; 55(1):93-97. PubMed ID: 8278214
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Predictors of prescription of morphine for severe cancer pain by physicians in Korea.
    Yun YH; Park SM; Lee K; Chang YJ; Heo DS; Kim SY; Hong YS; Huh BY
    Ann Oncol; 2005 Jun; 16(6):966-71. PubMed ID: 15857848
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Neurocognitive predictors of adherence to an online pain self-management program adjunct to long-term opioid therapy.
    Fleck DE; Wilson M; Lewis D; Welge JA; Arya G; Sathyan A; Cohen K; Winhusen TJ
    J Clin Exp Neuropsychol; 2023 May; 45(3):242-254. PubMed ID: 37278690
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Crosstalk between Sleep Disturbance and Opioid Use Disorder: A Narrative Review.
    Fathi HR; Yoonessi A; Khatibi A; Rezaeitalab F; Rezaei-Ardani A
    Addict Health; 2020 Apr; 12(2):140-158. PubMed ID: 32782736
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.
    Angarita GA; Emadi N; Hodges S; Morgan PT
    Addict Sci Clin Pract; 2016 Apr; 11(1):9. PubMed ID: 27117064
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The cognitive effects of opioids in cancer: a systematic review.
    Kurita GP; Lundorff L; Pimenta CA; Sjøgren P
    Support Care Cancer; 2009 Jan; 17(1):11-21. PubMed ID: 18762994
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time.
    Banning A; Sjøgren P
    Clin J Pain; 1990 Jun; 6(2):91-5. PubMed ID: 2135009
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.
    Lauretti GR; Lima IC; Reis MP; Prado WA; Pereira NL
    Anesthesiology; 1999 Jun; 90(6):1528-33. PubMed ID: 10360847
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Continuous reaction time after single dose, long-term oral and epidural opioid administration.
    Sjøgren P; Banning AM; Christensen CB; Pedersen O
    Eur J Anaesthesiol; 1994 Mar; 11(2):95-100. PubMed ID: 8174541
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Intravenous versus subcutaneous morphine titration in patients with persisting exacerbation of cancer pain.
    Elsner F; Radbruch L; Loick G; Gaertner J; Sabatowski R
    J Palliat Med; 2005 Aug; 8(4):743-50. PubMed ID: 16128648
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Need of risk reevaluation in morphine dependence in pain patients].
    Boureau F; Luu M; Koskas-Sergent AS; Doubrere JF
    Therapie; 1992 Nov; 47(6):513-8. PubMed ID: 1363796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.